← Research library

Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation

Review of earlier studies · 2023

What was studied
Cardiovascular senescence, cell models and animal research
Main finding
Discusses KED and AEDR. The reported AEDR rat-infarction benefit cites US patent 7,662,789 as reference 123; it is not presented here as a newly recovered peer-reviewed animal trial.

Study data at a glance

Participants or experimental model
Cardiovascular senescence, cell models and animal research
Reported results
Discusses KED and AEDR. The reported AEDR rat-infarction benefit cites US patent 7,662,789 as reference 123; it is not presented here as a newly recovered peer-reviewed animal trial.
Study limitations and source details

Study limitations

  • Claims about AEDR detection in heart complex are review-reported; original analytical evidence remains a recovery target.
  • Patent examples and experimental biomarkers do not establish clinical cardiovascular protection.

Source details

Full-text XML checked, including AEDR discussion and patent reference 123.

Sources checked

Citation

ReviewFull text available

Khavinson V, Linkova N, Dyatlova A, Kantemirova R, Kozlov K. Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation Cells 12(1):106 (2023 issue; online December 2022). DOI 10.3390/cells12010106

Study source ↗ · DOI 10.3390/cells12010106 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards